Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Atorvastatin/Fenofibrate (LCP-AtorFen) Combination Therapy in Dyslipidemia

This study has been completed.
Information provided by:
Veloxis Pharmaceuticals Identifier:
First received: July 18, 2007
Last updated: April 11, 2008
Last verified: April 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):